Surveyor™ nuclease-based detection of p53 gene mutations in haematological malignancy

被引:27
作者
Mitani, Noriaki [1 ]
Niwa, Yoshimasa [1 ]
Okamoto, Yasuyuki [1 ]
机构
[1] Nara Med Univ Hosp, Cent Clin Lab, Kashihara, Nara 6348522, Japan
关键词
D O I
10.1258/000456307782268174
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background Surveyor(TM) nuclease is a new single-strand-specific endonuclease that cleaves heteroduplex DNA at a base-mismatch site in both DNA strands. We applied this enzyme to detection of p53 gene mutations in haematological malignancy. Methods DNA fragments including exons 5 and 6, and those including exons 7 and 8, of the p53 gene, were amplified by polymerase chain reaction using DNA samples extracted from bone marrow aspirates. Denaturation followed by gradual annealing of the amplified fragments formed a heteroduplex with a base-mismatch if a mutation existed because the DNA samples contained wild-type DNA derived from coexisting non-malignant cells. After cleavage by Surveyor nuclease, mutations were simply detected by gel electrophoresis as extra bands of shorter size. Results Somatic mutations were clearly detected by this method in three of 39 different samples and confirmed by sequencing. The limit of detection estimated by changing the proportion of heteroduplexes in hetero/homoduplexes was between 1/8 and 1/16. Conclusion We suggest that our method is not only simple, but also sensitive, compared with other complicated methods, and would therefore be useful in current clinical laboratory settings.
引用
收藏
页码:557 / 559
页数:3
相关论文
共 10 条
[1]   p53 intron 7 polymorphisms in urinary bladder cancer patients and controls [J].
Berggren, P ;
Hemminki, K ;
Steineck, G .
MUTAGENESIS, 2000, 15 (01) :57-60
[2]   DETECTION OF MUTATIONS BY CLEAVAGE OF DNA HETERODUPLEXES WITH BACTERIOPHAGE RESOLVASES [J].
MASHAL, RD ;
KOONTZ, J ;
SKLAR, J .
NATURE GENETICS, 1995, 9 (02) :177-183
[3]  
Mitani N, 2006, CLIN LAB, V52, P385
[4]  
Nollau P, 1997, CLIN CHEM, V43, P1114
[5]  
Oefner P. J., 1995, American Journal of Human Genetics, V57, pA266
[6]   TP53 in hematological cancer: Low incidence of mutations with significant clinical relevance [J].
Peller, S ;
Rotter, V .
HUMAN MUTATION, 2003, 21 (03) :277-284
[7]   Mutation detection using Surveyor™ nuclease [J].
Qiu, P ;
Shandilya, H ;
D'Alessio, JM ;
O'Connor, K ;
Durocher, J ;
Gerard, GF .
BIOTECHNIQUES, 2004, 36 (04) :702-+
[8]  
Scaffino M.F., 2004, TRANSGENICS, V4, P157
[9]   Enzymatic mutation detection technologies [J].
Yeung, A ;
Hattangadi, D ;
Blakesley, L ;
Nicolas, E .
BIOTECHNIQUES, 2005, 38 (05) :749-758
[10]   SCREENING FOR MUTATIONS BY ENZYME MISMATCH CLEAVAGE WITH T4 ENDONUCLEASE-7 [J].
YOUIL, R ;
KEMPER, BW ;
COTTON, RGH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (01) :87-91